Strain Profile
Save

Bifidobacterium lactis Bl-04

◔ Human-origin
Sequenced
Public genome assembly available

Bifidobacterium lactis BL-04 (also classified as B. animalis subsp. lactis BL-04) has been evaluated in several randomized controlled trials examining immune and skin-related outcomes, including allergy symptoms during birch pollen season and skin hydration and wrinkle appearance. In vitro work has characterized the strain's ability to utilize prebiotic oligosaccharides and produce short-chain fatty acids. Safety assessments have examined antibiotic resistance and genomic risk factors. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.

Where it's been studied

Share of this strain's 51 body-system-tagged papers that concern each system. Research coverage, not measured effect.

+5 more systems

Symptoms in the research

Share of this strain's 28 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.

+10 more symptoms

Research

80 papers reference this strain in the probiotic database.

Match confidence
2024 IN_VITRO
The effect of probiotic Bifidobacterium lactis Bl-04 on innate antiviral responses in vitro
· Heliyon
2023 RCT
Pathogenetic aspects of the development and treatment of antibiotic-associated diarrhea: the choice of a synbiotic from the standpoint of evidence-based medicine
· Meditsinskiy sovet = Medical Council
2022 RCT
Effects of Bifidobacterium animalis subsp. lactis Bl-04 on Skin Wrinkles and Dryness: A Randomized, Triple-Blinded, Placebo-Controlled Clinical Trial
· Dermato
2021 OTHER
Characterization of the Hydrogen Peroxide Stress Responses of Bifidobacterium longum and Bifidobacterium animalis subsp. Lactis
· Digital Commons - USU (Utah State University)
2021 RCT
A Brief Review on the First Evaluation of a Synbiotic Food Supplement in Birch Pollen Allergic Patients in an Allergen Exposure Chamber
· Journal of clinical research
2021 RCT
Effect of fermented milk on upper respiratory tract infection in adults who lived in the haze area of Northern China: a randomized clinical trial
· Pharmaceutical Biology
2021 OBSERVATIONAL
An Open-label, Multicenter Study to Assess the Efficacy and Safety of a Novel Probiotic Blend in Patients With Functional Gastrointestinal Symptoms
· Journal of Clinical Gastroenterology
2020 OBSERVATIONAL
S0502 An Open-Label, Multicenter Study to Assess the Efficacy and Safety of a Novel Probiotic Blend in Patients With Functional Gastrointestinal Disturbances
· The American Journal of Gastroenterology
2019 IN_VITRO
Inhibition of Antimicrobial Resistant Salmonella Heidelberg by a Synbiotic Combination of Prebiotics and Probiotics in an in Vitro Model (P20-011-19)
· Current Developments in Nutrition
2019 REVIEW
Health Benefits of a Combination Probiotics; FlorMidabil™
· International Journal of Probiotics and Prebiotics
2018 IN_VITRO
Absolute Enumeration of Probiotic Strains Lactobacillus acidophilus NCFM® and Bifidobacterium animalis subsp. lactis Bl-04® via Chip-Based Digital PCR
· Frontiers in Microbiology
2017 RCT
Intestinal microbiota is altered in patients with colon cancer and modified by probiotic intervention
· BMJ Open Gastroenterology
2017 ANIMAL
Safety evaluation of HOWARU® Restore (Lactobacillus acidophilus NCFM, Lactobacillus paracasei Lpc-37, Bifidobacterium animalis subsp. lactis Bl-04 and B. lactis Bi-07) for antibiotic resistance, genomic risk factors, and acute toxicity
· Food and Chemical Toxicology
2017 RCT
Effect of probiotic on innate inflammatory response and viral shedding in experimental rhinovirus infection – a randomised controlled trial
· Beneficial Microbes
2017 RCT
A randomized controlled trial of probiotics for Clostridium difficile infection in adults (PICO)
· Journal of Antimicrobial Chemotherapy
2015 OTHER
Additional file 1: of The GH5 1,4-β-mannanase from Bifidobacterium animalis subsp. lactis Bl-04 possesses a low-affinity mannan-binding module and highlights the diversity of mannanolytic enzymes
· Figshare
2015 OTHER
Additional file 2: of The GH5 1,4-β-mannanase from Bifidobacterium animalis subsp. lactis Bl-04 possesses a low-affinity mannan-binding module and highlights the diversity of mannanolytic enzymes
· Figshare
2015 OTHER
Additional file 12: of The GH5 1,4-β-mannanase from Bifidobacterium animalis subsp. lactis Bl-04 possesses a low-affinity mannan-binding module and highlights the diversity of mannanolytic enzymes
· Figshare
2015 OTHER
Additional file 11: of The GH5 1,4-β-mannanase from Bifidobacterium animalis subsp. lactis Bl-04 possesses a low-affinity mannan-binding module and highlights the diversity of mannanolytic enzymes
· Figshare
2014 OBSERVATIONAL
Multi-strain Symbiotic Preparations as a Novel Adjuvant Approach to Allergic Rhinitis
· Journal of Contemporary Immunology
Browse all 80 papers →

Discussion

Be the first to comment.

Sign in to join the discussion.

No comments yet.

Citations

Selected papers that name this strain.

  1. [1]
    Effect of fermented milk on upper respiratory tract infection in adults who lived in the haze area of Northern China: a randomized clinical trial
    · Pharmaceutical Biology · 2021
    PMID 34062085 →
  2. [2]
    Absolute Enumeration of Probiotic Strains Lactobacillus acidophilus NCFM® and Bifidobacterium animalis subsp. lactis Bl-04® via Chip-Based Digital PCR
    · Frontiers in Microbiology · 2018
    PMID 29696008 →
  3. [3]
    Effect of probiotic on innate inflammatory response and viral shedding in experimental rhinovirus infection – a randomised controlled trial
    · Beneficial Microbes · 2017
    PMID 28343401 →
  4. [4]
    Probiotic Lactobacillus acidophilus NCFM and Bifidobacterium animalis subsp lactis Bl-04 interactions with prebiotic carbohydrates using differential proteomics and protein characterization
    · · 2012
    Source →
  5. [5]
    Specific probiotics alleviate allergic rhinitis during the birch pollen season
    · World Journal of Gastroenterology · 2009
    PMID 19598302 →
  6. [6]
    Effects of seven potential probiotic strains on specific immune responses in healthy adults: a double-blind, randomized, controlled trial
    · FEMS Immunology & Medical Microbiology · 2008
    PMID 18422632 →